Back to Search
DAVID WATERHOUSE, MD
MD
Hematology & Oncology Physician
NPI: 1578557864IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
33573(KY)35065059(OH)
Education
UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
Class of 1985
Research & Publications (20)
Randomized phase II trial of gemcitabine plus weekly versus three-weekly paclitaxel in previously untreated advanced non-small-cell lung cancer.
PMID 17043094·Ann Oncol·2007
3-trial
A small tolerance for catheter displacement in high-dose rate prostate brachytherapy is necessary and feasible.
PMID 19616901·Int J Radiat Oncol Biol Phys·2010
8-other
Time course and recovery of arterial blood gases during exacerbations in adults with Cystic Fibrosis.
PMID 18718821·J Cyst Fibros·2009
8-other
Phase III study of immediate compared with delayed docetaxel after front-line therapy with gemcitabine plus carboplatin in advanced non-small-cell lung cancer.
PMID 19075278·J Clin Oncol·2009
3-trial
QLT0267, a small molecule inhibitor targeting integrin-linked kinase (ILK), and docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P-AKT levels, altered F-actin architecture and improved treatment outcomes in an orthotopic breast cancer model.
PMID 19409087·Breast Cancer Res·2009
7-preclinical
Sentinel node biopsy for the individualization of surgical strategy for cure of early-stage colon cancer.
PMID 19472012·Ann Surg Oncol·2009
1-meta
An examination of the prevalence of IDF- and ATPIII-defined metabolic syndrome in an Irish screening population.
PMID 19129978·Ir J Med Sci·2009
8-other
Evaluation of osmolality and pH of various concentrations of methotrexate, cytarabine, and thiotepa prepared in normal saline, sterile water for injection, and lactated Ringer's solution for intrathecal administration.
PMID 18772215·J Oncol Pharm Pract·2009
6-review
Simple adaptation of current abdominal aortic aneurysm screening programs may address all-cause cardiovascular mortality: prospective observational cohort study.
PMID 18440345·Am Heart J·2008
8-other
Irinophore C: a liposome formulation of irinotecan with substantially improved therapeutic efficacy against a panel of human xenograft tumors.
PMID 18281556·Clin Cancer Res·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 4350 MALSBARY RD
BLUE ASH, OH 45242 - Phone
- (513) 751-2273
Quick Facts
- NPI
- 1578557864
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 3
- Years in Practice
- 41
- Publications
- 20
Are you this provider?
Claim Your Profile